Publication: Evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis
Issued Date
2021-11-01
Resource Type
ISSN
19352735
19352727
19352727
Other identifier(s)
2-s2.0-85120675522
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
PLoS Neglected Tropical Diseases. Vol.15, No.11 (2021)
Suggested Citation
Premjit Amornchai, Viriya Hantrakun, Gumphol Wongsuvan, Vanaporn Wuthiekanun, Surasakdi Wongratanacheewin, Prapit Teparrakkul, T. Eoin West, David P. Aucoin, Nicholas P.J. Day, Paul J. Brett, Mary N. Burtnick, Narisara Chantratitra, Direk Limmathurotsakul Evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis. PLoS Neglected Tropical Diseases. Vol.15, No.11 (2021). doi:10.1371/journal.pntd.0009840 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/77692
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Evaluation of antigen-detecting and antibody-detecting diagnostic test combinations for diagnosing melioidosis
Abstract
Background Melioidosis, an infectious disease caused by Burkholderia pseudomallei, is endemic in many tropical developing countries and has a high mortality. Here we evaluated combinations of a lateral flow immunoassay (LFI) detecting B. pseudomallei capsular polysaccharide (CPS) and enzyme-linked immunosorbent assays (ELISA) detecting antibodies against hemolysin co-regulated protein (Hcp1) or O-polysaccharide (OPS) for diagnosing melioidosis. Methodology/Principal findings We conducted a cohort-based case-control study. Both cases and controls were derived from a prospective observational study of patients presenting with community-acquired infections and sepsis in northeast Thailand (Ubon-sepsis). Cases included 192 patients with a clinical specimen culture positive for B. pseudomallei. Controls included 502 patients who were blood culture positive for Staphylococcus aureus, Escherichia coli or Klebsiella pneu-moniae or were polymerase chain reaction assay positive for malaria or dengue. Serum samples collected within 24 hours of admission were stored and tested using a CPS-LFI, Hcp1-ELISA and OPS-ELISA. When assessing diagnostic tests in combination, results were considered positive if either test was positive. We selected ELISA cut-offs correspond-ing to a specificity of 95%. Using a positive cut-off OD of 2.912 for Hcp1-ELISA, the combination of the CPS-LFI and Hcp1-ELISA had a sensitivity of 67.7% (130/192 case patients) and a specificity of 95.0% (477/502 control patients). The sensitivity of the combination (67.7%) was higher than that of the CPS-LFI alone (31.3%, p<0.001) and that of Hcp1-ELISA alone (53.6%, p<0.001). A similar phenomenon was also observed for the combination of CPS-LFI and OPS-ELISA. In case patients, positivity of the CPS-LFI was associated with a short duration of symptoms, high modified Sequential (sepsis-related) Organ Failure Assessment (SOFA) score, bacteraemia and mortality outcome, while positivity of Hcp1-ELISA was associated with a longer duration of symptoms, low modified SOFA score, non-bacteraemia and survival outcome. Conclusions/Significance A combination of antigen-antibody diagnostic tests increased the sensitivity of melioidosis diagnosis over individual tests while preserving high specificity. Point-of-care tests for melioidosis based on the use of combination assays should be further developed and evaluated.